Method to determine a predominant immune signal in a breast cancer microenvironment
AssigneeBoard of Regents, The University of Texas System
InventorsIsaac CHAN, Lily XU, Kaitlyn SAUNDERS
Life of this patent
Estimating the term…
Abstract
Disclosures herein are directed to methods for classifying and characterizing cancer epithelial cells and analyzing their level of interaction with secondary cell populations in order to identify, modify or otherwise tailor immunotherapy and treatment modalities to a patient. Also disclosed are methods of identifying suitable patient candidates for immunotherapy treatments as well as methods of identifying targets of immunotherapies for the treatment and/or prevention of cancer.
Claims30
A method of classifying a cancer epithelial cell to a gene element group, the method comprising:
- (i) obtaining a set of expressed genes in the cancer epithelial cell;
- (ii) determining expression levels of genes in a plurality of gene sets and ranking the expression levels in each gene set to identify a gene set having highest gene expression;
- and
- (iii) assigning the cell to a gene element group corresponding to the gene set having highest gene expression.
3-11. (canceled)
A method of classifying an immune cell to an immune cell subset, the method comprising:
- (i) obtaining a set of expressed genes in the immune cell;
- (ii) determining expression levels of genes in a plurality of gene sets and ranking the expression levels in each gene set to identify a gene set having highest gene expression;
- and
- (iii) assigning the immune cell to an immune cell subset corresponding to the gene set having highest gene expression.
15-20. (canceled)
(canceled)
(canceled)
(canceled)
(canceled)
33-34. (canceled)
39-42. (canceled)
44-45. (canceled)
(canceled)
Dependencies are inferred from the claim text.